Netanyahu Says Israel ‘Will Continue to Fight’ Its Enemies

Israeli Prime Minister Benjamin Netanyahu attends a discussion at the Israeli Parliament Knesset in Jerusalem July 17, 2024. (Reuters)
Israeli Prime Minister Benjamin Netanyahu attends a discussion at the Israeli Parliament Knesset in Jerusalem July 17, 2024. (Reuters)
TT

Netanyahu Says Israel ‘Will Continue to Fight’ Its Enemies

Israeli Prime Minister Benjamin Netanyahu attends a discussion at the Israeli Parliament Knesset in Jerusalem July 17, 2024. (Reuters)
Israeli Prime Minister Benjamin Netanyahu attends a discussion at the Israeli Parliament Knesset in Jerusalem July 17, 2024. (Reuters)

Israeli Prime Minister Benjamin Netanyahu says Israel “will continue to fight” against its enemies.

Netanyahu delivered a recorded message late Monday to a government memorial service marking the Oct. 7, 2023, Hamas attacks.

Israel responded to the attacks with a military offensive that has devastated Gaza and inflicted heavy losses on the Hamas militant group. US-led ceasefire efforts have repeatedly faltered, and Israel has now turned its focus to a ground offensive in Lebanon against the Iran-backed Hezbollah party.

“As long as the enemy threatens our existence and the peace of our country, we will continue to fight,” Netanyahu said. “As long as our hostages are in Gaza, we will continue to fight. We will not give up on any of them. I won’t give up.”

The government ceremony was prerecorded, and Netanyahu did not attend.

Families of people killed in the Oct. 7 attack, hostages and soldiers who died fighting Hamas held a separate ceremony earlier Monday, skipping the official ceremony in a show of anger against the government.



Siga Technologies to Supply Mpox Therapy in Morocco

The Mohammed VI Tower in Rabat. (AFP)
The Mohammed VI Tower in Rabat. (AFP)
TT

Siga Technologies to Supply Mpox Therapy in Morocco

The Mohammed VI Tower in Rabat. (AFP)
The Mohammed VI Tower in Rabat. (AFP)

Drugmaker Siga Technologies said on Tuesday it would supply its therapy for mpox in Morocco as part of a contract in response to a request from the country's health ministry for protection against any potential outbreak of the disease.

Although the antiviral therapy Tpoxx has been available in Africa through clinical trials and the World Health Organization's emergency use access protocol to deal with the current outbreak of mpox virus, this agreement marks Siga's first commercial sale of the therapy on the continent, Reuters reported.

The therapy is approved in the US and Canada for the treatment of smallpox and authorized in Europe and the UK for smallpox, mpox, cowpox and complications from vaccinia virus.

The Africa Centres for Disease Control and Prevention stated last month that the outbreak is not under control, after the WHO declared it a public health emergency of international concern in August upon identifying the new variant.

Two cases of the disease have been confirmed in Morocco this year, according to the WHO.